Abstract
Despite significant advances in prevention and treatment, cardiovascular
disease remains the leading cause of death in economically advanced countries.
The developing world has also begun to experience a disconcerting growth in
prevalence, where the insurgence of CVD has exacerbated the risk factors
associated with indigenous communicable diseases. Keeping pace with
epidemiological change in both the developed and developing world constitutes
the overriding challenge for industrial players, and involves successfully
integrating into localised healthcare systems and reimbursement structures, in
addition to remaining aligned with product demand. In the medical device,
pharmaceutical and biotechnology industries, this challenge is being met with
a focus on products that reduce adverse effects, improve patient outcomes and
extend the range of formulations for existing indications.
‘Innovations in Cardiovascular Disease Management' is a new report
published by Business Insights that will examine the major developments
shaping the future of the cardiovascular industry. This report will analyse
the future potential of new and emerging products from the medical device,
pharmaceutical and biotechnology sectors, and measure their likely impact upon
the existing market. The extent to which these products can stimulate the
growth and development of the future market will also be assessed. Use this
report to evaluate the potential of new and emerging products in the treatment
of cardiovascular diseases, assess the strength of competitor pipelines and
identify future market opportunities...
View Cart
